Rentschler - Frank Mathias
Rentschler Biotechnologie is next, and the German contract development and manufacturing (CDMO) company has appointed Frank Mathias – former CEO at Medigene – to lead the company going forward.
Mathias takes over in April and replaces current CEO Nikolaus Rentschler, who will move to the Supervisory Board to concentrate on the further expansion of the Rentschler group.
“I am impressed by the dynamics and the strong commitment of the leaders and staff of this growing company. On this basis and owing to continuously positive developments on the market we will jointly lead Rentschler Biotechnologie to future success,” Mathias said.